Histological and virological long-term outcome in patients treated with interferon-α2b and ribavirin for chronic hepatitis C

Journal of Viral Hepatitis

Volumn 6, Issue 3, 1999, Pages 237-242

  Schvarcz, R ^a,b   Glaumann, H ^a,b   Reichard, O ^a,c   Weiland, O ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

Chronic hepatitis C; Fibrosis; HCV RNA; Interferon; Liver histology; Ribavirin

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033049156     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00156.x     Document Type: Article

References (14)

1. Schvarcz R, Ando Y, Sönnerborg A, Weiland O. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. J Hepatol 1995; 23 (suppl 2): 17-21.
2. Schvarcz R, Yun Z, Sönnerborg A, Weiland O. Combined treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virol 1995; 46: 43-47.
3. Reichard O, Norkrans G, Frydén A, Braconier J, Sönnerborg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351: 83-87.
4. Chemello L, Cavaletto L, Bernardinello E, Guido M, Pontisso P, Alberti A. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol 1995; 23 (suppl 2): 8-12.
5. Lai M-Y, Kao J-H, Yang P-M et al. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology 1996; 111: 1307-1312.
6. Yun Z, Lindh G, Weiland O, Johansson B, Sönnerborg A. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors. J Med Virol 1993; 39: 57-61.
7. Desmet V, Gerber M, Hoofnagle J, Manns M, Scheuer P. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
8. Reichard O, Glaumann H, Norkrans G et al. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alpha-2b treatment course. Liver 1994; 14: 169-174.
9. Schvarcz R, Glaumann H, Weiland O, Norkrans G, Wejstål R, Frydén A. Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis. Liver 1991; 11: 30-38.
10. Saracco G, Rosina F, Abate M et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alpha-2b. Hepatology 1993; 18: 1300-1305.
11. Marcellin P, Boyer N, Gervais A et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997; 127: 875-881.
12. Reichard O, Glaumann H, Fryden A et al. Two-year biochemical, virological and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alpha-2b treatment. Hepatology 1995; 21: 918-922.
13. Schvarcz R, Glaumann H, Weiland O. Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis. J Hepatol 1993; 18: 15-23.
14. Schalm S, Hansen B, Chemello L et al. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: a meta-analysis of individual patient data from European centers. J Hepatol 1997; 26: 961-966.